CN1031222A - 用作单胺氧化酶抑制前药的β-(氟亚甲基)-5-羟基色氨酸及衍生物 - Google Patents

用作单胺氧化酶抑制前药的β-(氟亚甲基)-5-羟基色氨酸及衍生物 Download PDF

Info

Publication number
CN1031222A
CN1031222A CN88103199A CN88103199A CN1031222A CN 1031222 A CN1031222 A CN 1031222A CN 88103199 A CN88103199 A CN 88103199A CN 88103199 A CN88103199 A CN 88103199A CN 1031222 A CN1031222 A CN 1031222A
Authority
CN
China
Prior art keywords
acid
compound
formula
formula compound
methylene radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN88103199A
Other languages
English (en)
Chinese (zh)
Inventor
伊恩A·麦克唐纳
迈克尔·G·帕尔弗里曼
琼-诺埃尔科勒德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Ltd filed Critical Merrell Dow Pharmaceuticals Ltd
Publication of CN1031222A publication Critical patent/CN1031222A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CN88103199A 1987-05-21 1988-05-20 用作单胺氧化酶抑制前药的β-(氟亚甲基)-5-羟基色氨酸及衍生物 Pending CN1031222A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/053,212 US4822812A (en) 1987-05-21 1987-05-21 β-(Fluoromethylene)-5-hydroxytryptophan and derivatives and their use as prodrugs for MAO inhibition
US053,212 1987-05-21

Publications (1)

Publication Number Publication Date
CN1031222A true CN1031222A (zh) 1989-02-22

Family

ID=21982670

Family Applications (1)

Application Number Title Priority Date Filing Date
CN88103199A Pending CN1031222A (zh) 1987-05-21 1988-05-20 用作单胺氧化酶抑制前药的β-(氟亚甲基)-5-羟基色氨酸及衍生物

Country Status (17)

Country Link
US (1) US4822812A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0291998A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2520285B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR960016521B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1031222A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR246952A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU605865B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1310973C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK169330B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI90531C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HU199790B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL86387A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO172576C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ224661A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH25384A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT87538B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA883442B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100588398C (zh) * 2002-05-09 2010-02-10 波利药物股份公司 用于治疗中枢神经系统紊乱的3-吲哚基丙酮酸的烯醇互变体基本纯的固体形式

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5488188A (en) * 1994-09-29 1996-01-30 Merrell Dow Pharmaceuticals Inc. Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof
US6972014B2 (en) * 2003-01-04 2005-12-06 Endocare, Inc. Open system heat exchange catheters and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2513597B2 (de) * 1975-03-27 1977-06-02 L-5-hydroxytryptophan-l-glutamatmonohydrat, verfahren zu seiner herstellung und arzneimittel
US4183858A (en) * 1977-07-01 1980-01-15 Merrell Toraude Et Compagnie α-Vinyl tryptophanes
FR2499076A1 (fr) * 1981-02-02 1982-08-06 Panmedica Laboratoires Nouveaux derives de l'acide ((indol-3 yl)-3 amino-2 propionyloxy)-2 acetique, procedes pour leur preparation et medicaments les contenant
US4454158A (en) * 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors
US4421767A (en) * 1981-06-01 1983-12-20 Merrell Toraude Et Compagnie Compounds and methods for treating depression
ZA855101B (en) * 1984-07-13 1986-05-28 Merrell Dow Pharma Fluoroallylaine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100588398C (zh) * 2002-05-09 2010-02-10 波利药物股份公司 用于治疗中枢神经系统紊乱的3-吲哚基丙酮酸的烯醇互变体基本纯的固体形式

Also Published As

Publication number Publication date
JPS63303965A (ja) 1988-12-12
FI90531B (fi) 1993-11-15
FI882360L (fi) 1988-11-22
DK169330B1 (da) 1994-10-10
IL86387A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-12-01
EP0291998A2 (en) 1988-11-23
ZA883442B (en) 1988-11-16
PH25384A (en) 1991-06-03
FI882360A0 (fi) 1988-05-19
HUT47905A (en) 1989-04-28
NO172576C (no) 1993-08-11
NO172576B (no) 1993-05-03
PT87538B (pt) 1992-09-30
NO882240L (no) 1988-11-22
US4822812A (en) 1989-04-18
AU1634788A (en) 1988-11-24
AR246952A1 (es) 1994-10-31
EP0291998A3 (en) 1989-01-25
DK278388D0 (da) 1988-05-20
HU199790B (en) 1990-03-28
KR880013891A (ko) 1988-12-22
DK278388A (da) 1988-11-22
PT87538A (pt) 1989-05-31
JP2520285B2 (ja) 1996-07-31
FI90531C (fi) 1994-02-25
CA1310973C (en) 1992-12-01
NO882240D0 (no) 1988-05-20
AU605865B2 (en) 1991-01-24
NZ224661A (en) 1990-08-28
HUT50117A (en) 1989-12-28
KR960016521B1 (ko) 1996-12-14
IL86387A0 (en) 1988-11-15

Similar Documents

Publication Publication Date Title
CN1239490C (zh) 制备西酞普兰的中间体的方法
FR2508035A1 (fr) Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
CN1505614A (zh) 制备氨氯地平马来酸盐的工艺
HK1038917A1 (zh) 作为磷酸二酯酶4抑制剂的取代1,8-二氮杂萘-4(1h)-酮类化合物
EP0527687A2 (fr) Nouveaux dérivés d'aryléthylamines, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
CN86105400A (zh) 茶醚
EP0506539A1 (fr) Nouveaux amides alkyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CN1366525A (zh) 制备纯西酞普兰的方法
CN1027503C (zh) 结晶4-(二正丙基)氨基-6-氨基羰基-1,3,4,5-四氢化苯并[cd]吲哚盐的制备方法
CN85101761A (zh) 新型色胺衍生物的制备方法和应用
JPS6129341B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN85105193A (zh) 制备苯并噻吩止腹泻剂方法
CN1443178A (zh) (r)-n-[5-甲基-8-(4-甲基哌嗪-1-基)-1,2,3,4-四氢-2-萘基]-4-吗啉代苯甲酰胺的新形态
CN1031222A (zh) 用作单胺氧化酶抑制前药的β-(氟亚甲基)-5-羟基色氨酸及衍生物
US4053509A (en) Substituted aryl and aralkyl amides
CN1307563A (zh) N-苯基-n′-苯丙基哌嗪衍生物及其制备方法
CN1409700A (zh) 制备具有抗肥胖和抗糖尿病性质的芳基乙醇胺衍生物的方法
WO1998025913A1 (fr) Nouveaux derives [3h]-benzoxazole-2-thiones et [3h]-benzothiazole-2-thiones substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPH05503718A (ja) 光学異性ヒダントインの分割方法
NO803835L (no) Fremgangsmaate for fremstilling av n-substiuerte alfa-aminosyrer
US4879305A (en) Use of β-(fluoromethylene)-5-hydroxytryptophan and derivatives as prodrugs and mao inhibition
JPH0737442B2 (ja) アニリン類及びベンジルアミン類から得られるベンジルセレノベンズアミド類、及びその製造方法
JPH0222252A (ja) 5―ヒドロキシトリプタミン―1a―受容体結合化合物
CN1126740C (zh) 哌啶羧酰胺衍生物的制备方法
US3903165A (en) Ethynylaryl amines and processes for their preparation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication